Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-08-03Stimulating the Brain to Improve Self-Awareness
-
CLINICAL_TRIALS study record update · 2022-07-26Validating Reward-related Biomarkers to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2022-07-07iTBS Can Increase Frontal Dopamine Release and Improve Glucose Metabolism in PET Dopamine Imaging of Patients With Schizophrenia.
-
CLINICAL_TRIALS study record update · 2022-07-07Non-Invasive Direct Current Stimulation for Cognition in Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-07-05Retrieval Practice in Patients With Schizophrenia : an Exploratory Study Using Descriptive Stories
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-06-27Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-06-14D-serine Augmentation of Neuroplasticity Based Auditory Learning in Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-06-10Role Functioning Changes in New Onset Symptoms
-
CLINICAL_TRIALS study record update · 2022-06-08Effects of Galantamine on Cognition
-
CLINICAL_TRIALS study record update · 2022-06-08Cognitive Training Delivered Remotely to Individuals With Psychosis
-
CLINICAL_TRIALS study record update · 2022-06-06The Minimal Effective Dose of Antipsychotic Medication in Older Patients With Schizophrenia: a PET Study.
-
CLINICAL_TRIALS study record update · 2022-06-03Glutamatergic System and Response to Clozapine in Patients With Treatment-Resistant Schizophrenia: a Prospective Proton Magnetic Resonance Spectroscopy Study
-
CLINICAL_TRIALS study record update · 2022-05-31Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy
-
CLINICAL_TRIALS study record update · 2022-05-23Research Into Antipsychotic Discontinuation and Reduction (RADAR): A Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-05-23Effects of Rhythmic Auditory Stimulation on Movements in Individuals at Risk for Psychotic Onset and Schizophrenia Patients
-
CLINICAL_TRIALS study record update · 2022-05-19Efficacy and Safety of High-frequency Repetitive Transcranial Magnetic Stimulation With H7-coil in the Treatment of Schizophrenia Negative Symptoms; A Multicenter, Randomized, Sham Controlled, Triple Blind Trial
-
CLINICAL_TRIALS study record update · 2022-05-06Magnetic Seizure Therapy for Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-05-04An Open Label Positron Emission Tomography (PET) Study to Evaluate Dopamine Receptor Occupancy of LB-102 Administered Orally to Healthy Subjects
-
CLINICAL_TRIALS study record update · 2022-05-02A Cluster Randomized, Pilot Trial of Coordinated, Co-produced Care to Reduce Excess Mortality and Improve Quality of Life in Patients With Severe Mental Illness in General Practice Setting
-
CLINICAL_TRIALS study record update · 2022-04-29Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia: A Randomised Placebo-controlled Double-blind Trial
-
CLINICAL_TRIALS study record update · 2022-04-29Effects of Transdermal Nicotine on Response Inhibition to Emotional Cues in Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-04-28A Multicenter, Open-label, Clinical Pharmacology Trial to Determine the Pharmacokinetics, Tolerability, and Safety of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-04-27A Single-arm, Single-blind, Multiple Dose Study to Evaluate Safety and the Effects of RL-007 on Electroencephalograms and Event-related Potentials in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2022-04-27A Multicentre 12-week Randomised Double-blind Placebo Controlled Feasibility Trial of Sodium Benzoate and/or N-acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.
-
CLINICAL_TRIALS study record update · 2022-04-27A Phase 1, Open-label Trial to Evaluate the Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations Under Fasted and Fed Conditions in Healthy Participants